What is William Blair's Estimate for MRSN Q1 Earnings?
Mersana Therapeutics, Inc. (NASDAQ:MRSN - Free Report) - Investment analysts at William Blair issued their Q1 2025 earnings per share estimates for shares of Mersana Therapeutics in a research report issued to clients and investors on Monday, March 3rd. William Blair analyst A. Hsieh expects that.
Publicado el: 2025-03-07 12:18:56
Autor: lulegacy, Fuente: lulegacy
Compartir: 
